These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7471135)
1. The significance of tuberculin immunity testing in cancer patients. Mujagić H; Desković M; Malenica B; Bistrović M; Nola P; Krusić J Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):111-21. PubMed ID: 7471135 [No Abstract] [Full Text] [Related]
2. Adoptive transfer of delayed skin hypersensitivity to tuberculin with human "immune" RNA. Han T; Mittelman A; Murphy GP Surg Forum; 1973; 24():281-3. PubMed ID: 4806009 [No Abstract] [Full Text] [Related]
3. [The tuberculin test in cancer patients]. Yarom J; Robinson E Harefuah; 1972 Dec; 83(12):542-3. PubMed ID: 4659021 [No Abstract] [Full Text] [Related]
4. [Study of delayed hypersensitivity to tuberculin in 130 cancerous adults. Effects of BCG]. Israel L; Mawas C; Bouvrain A; Mannoni P; Sors C Pathol Biol; 1967; 15(11):597-601. PubMed ID: 4860736 [No Abstract] [Full Text] [Related]
5. [Value of the tuberculin test and stimulation with BCG for evaluations of the immunological state of surgical patients, especially those with neoplasms]. Lorenzini L; Mancini S; Tota G Minerva Med; 1972 Feb; 63(8):437-45. PubMed ID: 5061514 [No Abstract] [Full Text] [Related]
6. Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects. Han T; Pauly JL; Mittelman A Immunology; 1975 Jan; 28(1):127-32. PubMed ID: 1116867 [TBL] [Abstract][Full Text] [Related]
7. Induction of tuberculin hypersensitivity and serologic unresponsiveness to tubercle bacilli in newborn and young guinea pigs. Janicki BW; Aron SA J Immunol; 1968 Jul; 101(1):121-7. PubMed ID: 4969525 [No Abstract] [Full Text] [Related]
8. Delayed-type hypersensitivity and immunoglobulin levels in the course of chemotherapy of advanced malignant neoplasms. Singer Z; Salwa J Arch Immunol Ther Exp (Warsz); 1973; 21(2):239-47. PubMed ID: 4581915 [No Abstract] [Full Text] [Related]
9. [Immunological cell-type reaction in patients with and without malignant tumors]. Pavelić Z; Boranić M; Milas L Lijec Vjesn; 1973 Feb; 95(2):62-7. PubMed ID: 4121020 [No Abstract] [Full Text] [Related]
10. Proceedings: The significance of the tuberculin reaction as indicator of cell-mediated immunity in man. Long DA Ann Sclavo; 1971; 13(6):777-86. PubMed ID: 5163535 [No Abstract] [Full Text] [Related]
11. [Tuberculin allergy and malignant diseases]. Chollet P; Rey M Nouv Presse Med; 1973 Feb; 2(6):381. PubMed ID: 4569123 [No Abstract] [Full Text] [Related]
12. Delayed-hypersensitivity skin testing and childhood cancer. Munzarová M; Kubíková-Kourilová A; Kolcová V Br J Cancer; 1982 Jun; 45(6):968-70. PubMed ID: 7093127 [No Abstract] [Full Text] [Related]
13. Immunologic responses in cancer patients. Solowey AC; Rapaport FT Surg Forum; 1965; 16():100-1. PubMed ID: 5835105 [No Abstract] [Full Text] [Related]
14. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. Tripodi D; Parks LC; Brugmans J N Engl J Med; 1973 Aug; 289(7):354-7. PubMed ID: 4718515 [No Abstract] [Full Text] [Related]
15. [Cutaneous immune response to Candidin, PPD and Varidase in cancer patients. Modifying factors]. Ballesteros P; Cueto J; Rodríguez Rubio P; Talavera C; López Somoza M; Pedraza V; García Puche JL Rev Clin Esp; 1980 Oct; 159(1):37-42. PubMed ID: 6936743 [No Abstract] [Full Text] [Related]